Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joy A. Awosika
Observed names:
Awosika, Joy,
J. Awosika,
Joy A Awosika,
Joy Awosika
Observed institutions:
Henry M. Jackson Foundation,
National Institutes of Health,
Naval Medical Research Command,
National Cancer Institute,
Center for Cancer Research,
University of Cincinnati,
University of Cincinnati Medical Center
show all 7
ORCID:
0000-0001-6074-4771
Observed ORCID:
0000-0001-6074-4771
OpenAlex ID:
A5037229059
Genomic Comparison of Escherichia coli O104:H4 Isolates from 2009 and 2011 Reveals Plasmid, and Prophage Heterogeneity, Including Shiga Toxin Encoding Phage stx2
2012
·
Sanaa A. Ahmed
, Joy Awosika
, et al.
·
PLoS ONE
·
124
PDF
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19
2022
·
Ziad Bakouny
, Chris Labaki
, et al.
·
JAMA Oncology
·
54
PDF
Deficient Mismatch Repair and Microsatellite Instability in Solid Tumors
2025
·
Joy A. Awosika
, James L. Gulley
, et al.
·
International Journal of Molecular Sciences
·
30
PDF
Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab
2025
·
Yuta Myojin
, Sepideh Babaei
, et al.
·
Gut
·
24
Scanning the Landscape of Genome Architecture of Non-O1 and Non-O139 Vibrio cholerae by Whole Genome Mapping Reveals Extensive Population Genetic Diversity
2015
·
Carol Chapman
, Matthew Henry
, et al.
·
PLoS ONE
·
23
PDF
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study
2022
·
Gowri Satyanarayana
, Kyle T Enriquez
, et al.
·
Open Forum Infectious Diseases
·
19
PDF
A narrative review of systemic treatment options for hepatocellular carcinoma: state of the art review
2022
·
Joy Awosika
, Davendra Sohal
·
Journal of Gastrointestinal Oncology
·
12
PDF
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19
2023
·
Shuchi Gulati
, Chih-Yuan Hsu
, et al.
·
JAMA Oncology
·
10
PDF
A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas
2024
·
Pankaj B. Desai
, Aniruddha S. Karve
, et al.
·
Clinical Cancer Research
·
9
Integration of circulating tumor DNA in biliary tract cancer: the emerging landscape
2024
·
Joy A Awosika
, Cecilia Monge
, et al.
·
Hepatic Oncology
·
8
Genome Sequencing of 15 Clinical Vibrio Isolates, Including 13 Non-O1/Non-O139 Serogroup Strains
2014
·
Kimberly A. Bishop-Lilly
, Shannon L. Johnson
, et al.
·
Genome Announcements
·
8
Altering the gut microbiome and tumor microenvironment in advanced liver cancer: A phase II study of nivolumab, tadalafil and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancers
2025
·
Chi Ma
, Joy A. Awosika
, et al.
·
Cancer Letters
·
5
Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis
2024
·
Amit A. Kulkarni
, Cassandra Hennessy
, et al.
·
Clinical Lung Cancer
·
4
Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study
2023
·
Gayathri Nagaraj
, Shaveta Vinayak
, et al.
·
eLife
·
3
Altering the gut microbiome and TME in advanced liver cancers: A phase II study of nivolumab, tadalafil, and oral vancomycin in refractory HCC or liver-dominant metastatic CRC or PDAC.
2024
·
Kelley Coffman D'Annibale
, Chi Ma
, et al.
·
Journal of Clinical Oncology
·
2
The efficacy-associated biomarkers for immune checkpoint inhibitors in gastrointestinal cancer: a literature review
2024
·
Peixi Zhao
, Rui Jin
, et al.
·
Journal of Gastrointestinal Oncology
·
2
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma
2023
·
Douglas B. Johnson
, Michael B. Atkins
, et al.
·
BMC Cancer
·
2
PDF
Combined treatment of durvalumab, bevacizumab and tremelimumab in subjects with hepatocellular carcinoma (HCC) or biliary tract carcinoma (BTC).
2025
·
Joy Awosika
, M. Cecilia Monge B.
, et al.
·
Journal of Clinical Oncology
·
1
Efficacy and safety of regorafenib as second-line treatment for patients with hepatocellular carcinoma and macrovascular invasion and(or) extrahepatic metastasis
2023
·
Yan Zhao
, Weiling Liu
, et al.
·
Journal of Gastrointestinal Oncology
·
1
Author response: Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study
2023
·
Gayathri Nagaraj
, Shaveta Vinayak
, et al.
·
1
PDF
COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease
2023
·
Melissa Y.Y. Moey
, Cassandra Hennessy
, et al.
·
Translational Oncology
·
1
71 Molecular Classification and Spatial Characterization of Intrahepatic Cholangiocarcinoma
2026
·
Kenta Makino
, Peter M. Richieri
, et al.
·
Gastrointestinal Endoscopy
71 Molecular Classification and Spatial Characterization of Intrahepatic Cholangiocarcinoma
2026
·
Kenta Makino
, Peter M. Richieri
, et al.
·
Gastroenterology
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a CCC19 registry analysisImpact of B-cell malignancy therapy on COVID-19 outcomes
2025
·
Li, Xuanyi
, Kuderer, Nicole M
, et al.
·
Carolina Digital Repository (University of North Carolina at Chapel Hill)
Data from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas
2024
·
Pankaj B. Desai
, Aniruddha S. Karve
, et al.
Show more works
View as search
Works count:
53
Citation count:
342
H-index:
9
I10-index:
8
Year
Topic
Type
